La Unidad de Desarrollo e Investigación en Bioprocesos
Servicios
Publicaciones Relevantes
UDIBI
Quality attributes of partially hydrolyzed collagen in a liquid formulation used for skin care.
UDIBI
Sequencing Analysis and Identification of the Primary Peptide Component of the Dialyzable Leukocyte Extract “Transferon Oral”: The Starting Point to Understand Its Mechanism of Action
UDIBI
Characterization of a Complex Mixture of Immunomodulator Peptides Obtained from Autologous Urine
UDIBI
Taking advantage of a high-throughput flow cytometer for the implementation of an ADCC assay for regulatory compliance
UDIBI
Development and validation of a mass spectrometric method to determine the identity of rituximab based on its microheterogeneity profile. IN PRESS
UDIBI
Validation of a cell proliferation assay to assess the potency of a Dialyzable Leucocyte Extract intended for batch release
UDIBI
Identity Profiling of Complex Mixtures of Peptide Products by Structural and Mass Mobility Orthogonal Analysis
UDIBI
Development of Functional Antibodies Directed to Human Dialyzable Leukocyte Extract (Transferon®)
UDIBI
Validation of a cell-based colorimetric reporter gene assay for the evaluation of Type I Interferons.
UDIBI
CD80 Expression Correlates with IL-6 Production in THP-1-Like Macrophages Costimulated with LPS and Dialyzable Leukocyte Extract (Transferon®)
UDIBI
Determination of Peptide Profile Consistency and Safety of Collagen Hydrolysates as Quality Attributes.
UDIBI
Validation of an ADCC assay using human primary natural killer cells to evaluate biotherapeutic products bearing an Fc región
UDIBI
Mycobacterium tuberculosis Catalase Inhibits the Formation of Mast Cell Extracellular Traps
UDIBI
Determination of Peptide Profile Consistency and
Safety of Collagen Hydrolysates as Quality
Attributes
UDIBI
Transcriptome-based identification of lovastatin as a breast cancer stem cell-targeting drug
UDIBI
Development and validation of a bioassay to evaluate binding of adalimumab to cell membrane-anchored TNFα using flow cytometry detection
UDIBI
Progress and Challenges in the Design and Clinical Development of Antibodies for Cancer Therapy
UDIBI
The dialyzable leukocyte extract TransferonTM inhibits tumor growth and brain metastasis in a murine model of prostate cancer
Nuestro Equipo
Noticias y Eventos
2020Anticuerpos: Desde su origen hasta su desarrollo como agentes terapéuticos
Clase online – Impartido por la Dra.Martha Pedraza y Dra.Sonia Mayra Pérez
2020Congreso Sociedad Mexicana de Inmunología
PARTICIPACIÓN INTEGRANTES UDIBI CON POSTERS Y PONENCIAS DRA MAYRA
2020
2020
2020
2020XXVIII Congreso de Educación Química Farmacéutica Biológica y a la XXIV Reunión Nacional de Estudiantes de Farmacia
Conferencia de producción de productos biotecnológicos
2020Contacto
En UDIBI contamos con un equipo multidisciplinario altamente calificado y con amplia experiencia capaz de proveer servicios relacionados con el descubrimiento, desarrollo, fabricación y caracterización de productos biofarmacéuticos. En UDIBI nos esforzamos en ofrecer la solución más adecuada que satisfaga y supere las expectativas de nuestros clientes.
